Impact of Cerebrovascular Disease on Survival Benefits from Local Treatment in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer.
Tae-Jin KimYoung Dong YuDong Soo ParkKoon Ho RhaSung Joon HongKang Su ChoByung Ha ChungKyo Chul KooPublished in: Yonsei medical journal (2020)
Local treatment with or without metastasis-directed therapy may provide OS advantages for mHSPC patients without a history of CVD. Further prospective studies are needed to address these important concerns.